RxDoctor Payments Data

Elizabeth Illing

Family · Gainesville, GANPI 1851721161

Payments from drug & device makers

$4,132in general payments, 2019–2025

Across 207 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$507
  • Amgen$457
  • Johnson & Johnson$445
  • Esperion Therapeutics, Inc.$434
  • Jazz Pharmaceuticals Inc.$277
  • Impulse Dynamics (USA) Inc.$267
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,132 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban284$307,737
EntrestoSacubitril/Valsartan84$100,004
XareltoRivaroxaban44$53,037
MultaqDronedarone Hcl28$51,676
Repatha SureclickEvolocumab26$19,429
JardianceEmpagliflozin13$13,260
Praluent PenAlirocumab11$11,277
Ezetimibe405$8,935
Metoprolol Succinate402$7,369
Flecainide Acetate191$7,347
Atorvastatin Calcium505$4,803
Losartan Potassium329$4,273
Olmesartan Medoxomil216$4,124
Rosuvastatin Calcium236$3,031
Nebivolol Hcl47$2,474

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$212$307,737284 claims
NovartisEntresto$507$100,00484 claims
Johnson & JohnsonXarelto$445$53,03744 claims
Sanofi-aventis U.S. LLCMultaq$22$51,67628 claims
Boehringer IngelheimJardiance$208$13,26013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →